A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

NCT00057564 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

470

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: A (Thalidomide + Dexamethasone)
DRUG: B (Placebo + Dexamethasone)

Sponsor

Celgene Corporation